And the treatment for metastatic disease is finding Sir Spheres as the cornerstone for metastatic disease to the liver which is a multibillion dollar market yet the entire market cap of SRX is 150 million USD. There is a lot of room for growth.
very positive sirtex and genentech news, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $356.3K | 2.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2482400 | 31 |
View Market Depth
| Last trade - 15.59pm 09/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |